Copyright
©The Author(s) 2020.
World J Clin Oncol. Aug 24, 2020; 11(8): 614-628
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.614
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.614
Gene | Target codon | Restriction enzyme/site | Fragment size | ||
Undigested | Mutant after digestion | Wild-type/normal after digestion | |||
K-Ras | 12 Glycine (GGT) to Valine (GTT)/Aspartic acid (GAT)/Serine (AGT)/Arginine (CGT)/Alanine (GCT)/Cysteine (TGT) | MvaI (BstNI) | 144 bp | 144 bp | 115 bp and 29 bp |
CC↓ WGG | |||||
GGW↑ CC | |||||
K-Ras | 13 Glycine (GGC) to Aspartic acid (GAC) | HphI | 144 bp | 101 bp and 43 bp | 144 bp |
GGTGAN8↓ | |||||
CCACTN7↑ | |||||
H-Ras | 12 Glycine (GGC) to Valine (GTC)/Aspartic acid (GAC)/Serine (AGC)/Alanine (GCC) | Mspl (HpaII) | 420 bp | 420 bp | 390 bp and 30 bp |
(C↓ CGG) | |||||
(GGC↑ C) | |||||
N-Ras | 61 Glutamine (CAA) to Arginine (CGA)/Lysine (AAA)/Leucine (CTA) | Mlsl (MscI) | 65 bp | 65bp | 44 bp and 21 bp |
(TGG↓ CCA) | |||||
(ACC↑ GGT) |
- Citation: Tripathi K, Goel A, Singhai A, Garg M. Mutational analysis of Ras hotspots in patients with urothelial carcinoma of the bladder. World J Clin Oncol 2020; 11(8): 614-628
- URL: https://www.wjgnet.com/2218-4333/full/v11/i8/614.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i8.614